Navigation Links
Stereotaxis Reports Third Quarter 2008 Financial Results
Date:11/6/2008

Backlog Reaches $75 Million $20 Million Existing Commitment from Two Shareholders Extended into 2010

Significantly Expands Operating Flexibility Evaluation of Magnetic Irrigated Catheter in Europe Results in Excellent

Outcomes

ST. LOUIS, Nov. 6 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) today reported its financial results for the third quarter ended September 30, 2008. Revenue for the third quarter of 2008 was $10.6 million as the Company recognized revenue on six Niobe(R) Magnetic Navigation Systems and shipped three additional systems for which it expects to recognize revenue in the fourth quarter of 2008 and first quarter of 2009. Revenue from Niobe(R) and Odyssey(TM) systems totaled $7.4 million, while disposables, services and accessories revenue was $3.2 million. Revenue in the third quarter of 2007 was $12.0 million. Operating expenses in the recent third quarter declined by $2.6 million, or 14% from the third quarter of last year, and $1.5 million, or eight percent compared to the second quarter of 2008, excluding the costs related to the re-engineering of the magnetic irrigated catheter in the second quarter.

"While the hospital capital equipment market has been impacted by the credit crisis, electrophysiology (EP) lab spending on projects, programs and systems that help build overall hospital revenue remains relatively robust and we are capitalizing on the value that Stereotaxis brings to the marketplace," said Bevil Hogg, Chief Executive Officer. "During the quarter, we set an all time high for recurring revenue, set a new record for backlog and generated $13 million in new orders. We are also poised to accelerate our momentum in the market as our partner Biosense Webster has completed the patient enrollment for the external evaluation of our partnered magnetic irrigated catheter. The catheter has been evaluated at nine sites, primarily in E
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Stereotaxis Announces New Management Appointment
2. Stereotaxis Reports Record Second Quarter Revenue
3. Stereotaxis Announces Second Quarter 2008 Earnings Release Date and Conference Call
4. Stereotaxis Magnetic Navigation System Used to Successfully Treat an Inoperable Congenital Heart Defect in a 10-Year Old Patient
5. Stereotaxis Reports Record First Quarter Orders
6. Stereotaxis to Present at the Deutsche Bank 33rd Annual Health Care Conference
7. Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases
8. Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
9. Stereotaxis Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
10. Stereotaxis to Present at the Deutsche Bank Small- and Mid-Cap Growth Conference
11. Stereotaxis Receives $20 Million in Additional Loan Commitments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... (PRWEB) May 28, 2015 Workers’ compensation costs ... typical state, a recent study by the Workers Compensation ... over a three-year period. , The WCRI study, CompScope™ ... which workers missed seven days or more of work with ... the average 2011 Michigan claim was 4 percent lower than ...
(Date:5/28/2015)... May 28, 2015 Senior Housing Assistance ... Lou Piniella, who managed the Seattle Mariners team that ... will appear in television and digital advertising for SHAG ... apartment communities, including several new communities slated to open ... Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University Place. , ...
(Date:5/28/2015)... May 28, 2015 Nidra Herbal Sleep Supplement ... on the body. A non-addictive supplement, Nidra Herbal Sleep Supplement ... natural ingredients will leave users with a real sense of ... care , Ayurveda, which translates as the “Science or Knowledge ... years ago and is a holistic system of knowledge which ...
(Date:5/28/2015)... VA (PRWEB) May 28, 2015 More ... Frozen Yogurt will raise money to help the Muscular ... fighting muscular dystrophy and related life-threatening diseases that limit ... Summer Camp mobile program. , From June 1 to ... that offer customers the opportunity to help send local ...
(Date:5/28/2015)... May 28, 2015 Ticket Down is a ... match between Mexico and Argentina in early September. ... world will compete on the pitch at AT&T Stadium in ... in an international friendly on Tuesday, September 8th at 9 ... nations in the world including some of the most loved ...
Breaking Medicine News(10 mins):Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:Ayurveda Herba Corp’s Revolutionary Herbal Sleep Supplement is Now Available from Amazon.com 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 2Health News:sweetFrog and MDA Join Forces to Send Kids with Muscle Disease to Summer Camp 3Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3
... Thursday, elderly persons who had failed to receive information on ... insurance by Medicare, will be given an extra time period ... ,The Health Care Financing Administration, U.S. of the ... ,Medicare is the primary federal health care program ...
... cholesterol-lowering drugs do increase the risk of painful inflammation ... according to Sonal Singh, M.D., from Wake Forest University ... a fairly common condition and cholesterol-lowering drugs have been ... people around the world take these drugs, our aim ...
... has shown that GlaxoSmithKline's Tykerb along with Roche's Xeloda ... HER2// positive advanced breast cancer, where the disease had ... the findings, researchers opined that, Tykerb should be checked ... HER2 positive breast cancer. ,"Patients with advanced ...
... caught the attention of the ministry. Zoltan Nagy, intervening ... to being aware of five to 10 private clinics ... but refuses to disclose the names or exact number ... come up because the legislation binds only doctors to ...
... diseases.,A potbelly indicates that the risk of a heart attack// ... skinny as a beanpole. ,This new study suggests ... waist size to the hips, an elevated waist-to-hip ratio predicts ... even people who would otherwise be considered safe going by ...
... exercise by doing household chores like dusting, mopping and ... a new study.// ,The research funded by ... European countries and found that doing housework was far ... edition of BBC News. , ,It was earlier ...
Cached Medicine News:Health News:Risk of Acute Pancreatitis Low With Statins 2Health News:Pot Belly Is A Better Risk Predictor Of Heart Attack Than BMI 2
(Date:5/28/2015)...  The recent flurry of PBM mergers and ... scrambling to identify a pharmacy benefit manager that ... retail pharmacy chain, or other potentially conflicting entity. ... Catamaran, Rite Aid,s $2 billion acquisition of EnvisionRx, ... $10 billion are just the latest examples of ...
(Date:5/28/2015)... May 28, 2015   Sanovas, Inc., a rapidly ... the Top 50 Start-Up Companies in the World at the Silicon ... Logo - http://photos.prnewswire.com/prnh/20150528/219097LOGO ... segment experts with direct domain experience screened 2,716 companies from ... Property, Business Model, and Team. This select list was further ...
(Date:5/28/2015)... 28, 2015  Array BioPharma Inc. (NASDAQ: ARRY ... (licensed to AstraZeneca) at the 2015 American Society of ... May 29 – June 2, 2015 in ... advancing in a total of 6 pivotal trials, with ... (binimetinib monotherapy in NRAS mutant melanoma patients) and SUMIT ...
Breaking Medicine Technology:Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3Sanovas Awarded Global "Top-50" Start-Up Company 2Sanovas Awarded Global "Top-50" Start-Up Company 3Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3
... /PRNewswire/ -- Asenapine -- an,investigational drug being developed ... Nobel, for bipolar I disorder and,schizophrenia -- was ... acute manic and mixed episodes associated with bipolar,I ... a study,presented at the American Psychiatric Association's 2007 ...
... Presented at 2007 APA Meeting -, COLLEGEVILLE, ... four new studies examining safety and efficacy ... studied as a potential treatment for adults,with ... at the,2007 American Psychiatric Association annual meeting ...
Cached Medicine Technology:Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 2Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 3Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8
A straight suture punch with 2.5 mm needle and 2/0 to #1 monofilament suture....
... provide superior tissue excision with precision-matched, diamond-honed ... tooth pattern to capture loose bodies drawn ... stress pin buffering system to minimize tip ... stress pin buffering system applies increasing tension ...
Athroscopic leg holder system....
... Featuring two rapid response roller-pumps, ... maintaining a clear surgical field. Furthermore ... surgeon total control over intra-articular pressure ... system includes foot pedal controls, providing ...
Medicine Products: